QQ客服 官方微博 反馈留言

	Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis
	Han, Yiqun; Wang, Jiayu; Liu, Weiming; Yuan, Peng; Li, Qing; Zhang, Pin; Ma, Fei; Luo, Yang; Fan, Ying; Chen, Shanshan
	2019
卷号	11页码:4699-4706
关键词	trastuzumab retreatment HER2-positive cancer metastatic cancer of the breast progression therapy
ISSN号	1179-1322
DOI	10.2147/CMAR.S198962
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6340056
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Han, Yiqun,Wang, Jiayu,Liu, Weiming,et al. Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis[J],2019,11:4699-4706.
APA	Han, Yiqun.,Wang, Jiayu.,Liu, Weiming.,Yuan, Peng.,Li, Qing.,...&Xu, Binghe.(2019).Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis.,11,4699-4706.
MLA	Han, Yiqun,et al."Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis".11(2019):4699-4706.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。